[go: up one dir, main page]

MXJL03000001A - Metodos de ensayo de canales de iones. - Google Patents

Metodos de ensayo de canales de iones.

Info

Publication number
MXJL03000001A
MXJL03000001A MXJL03000001A MXJL03000001A MXJL03000001A MX JL03000001 A MXJL03000001 A MX JL03000001A MX JL03000001 A MXJL03000001 A MX JL03000001A MX JL03000001 A MXJL03000001 A MX JL03000001A MX JL03000001 A MXJL03000001 A MX JL03000001A
Authority
MX
Mexico
Prior art keywords
ion channel
assay methods
channel assay
candidate compound
cells
Prior art date
Application number
MXJL03000001A
Other languages
English (en)
Inventor
Maher Michael
Original Assignee
Vertex Pharma San Diego Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/804,580 external-priority patent/US6686193B2/en
Application filed by Vertex Pharma San Diego Llc filed Critical Vertex Pharma San Diego Llc
Publication of MXJL03000001A publication Critical patent/MXJL03000001A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXJL03000001A 2000-07-10 2001-07-09 Metodos de ensayo de canales de iones. MXJL03000001A (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US21767100P 2000-07-10 2000-07-10
US21766600P 2000-07-10 2000-07-10
US21722100P 2000-07-10 2000-07-10
US21721900P 2000-07-10 2000-07-10
US09/804,580 US6686193B2 (en) 2000-07-10 2001-03-12 High throughput method and system for screening candidate compounds for activity against target ion channels
US09/804,480 US7312043B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods
US09/804,458 US6969449B2 (en) 2000-07-10 2001-03-12 Multi-well plate and electrode assemblies for ion channel assays
US09/804,457 US7399599B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods
PCT/US2001/021652 WO2002008748A2 (en) 2000-07-10 2001-07-09 Ion channel assay methods

Publications (1)

Publication Number Publication Date
MXJL03000001A true MXJL03000001A (es) 2004-02-09

Family

ID=27575195

Family Applications (1)

Application Number Title Priority Date Filing Date
MXJL03000001A MXJL03000001A (es) 2000-07-10 2001-07-09 Metodos de ensayo de canales de iones.

Country Status (10)

Country Link
EP (2) EP1757932B1 (es)
JP (1) JP5209835B2 (es)
AT (2) ATE480771T1 (es)
AU (4) AU2001275881B2 (es)
CA (1) CA2413711C (es)
DE (2) DE60143064D1 (es)
DK (1) DK1303757T3 (es)
ES (1) ES2273868T3 (es)
MX (1) MXJL03000001A (es)
WO (1) WO2002008748A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144905A1 (en) 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US7244349B2 (en) 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
DE60143064D1 (de) * 2000-07-10 2010-10-21 Vertex Pharma San Diego Llc Ionenkanal-Assayverfahren
US7615356B2 (en) * 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
US7067046B2 (en) 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
EP1425065A4 (en) * 2001-07-12 2004-12-15 Merck & Co Inc ELECTRIC FIELD STIMULATION WITH EUKARYONTIC CELLS
EP1438385A1 (en) * 2001-10-25 2004-07-21 Bar-Ilan University Interactive transparent individual cells biochip processor
EP1472538A2 (en) 2002-02-05 2004-11-03 The University of Glasgow, University Court Device for performing cell assays
AU2003283663A1 (en) * 2002-11-01 2004-05-25 Cellectricon Ab Computer programs,workstations, systems and methods for microfluidic substrates in cell
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
ATE376454T1 (de) * 2004-03-15 2007-11-15 Amaxa Ag Behältnis und vorrichtung zur erzeugung von elektrischen feldern in einzelnen reaktionsräumen
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
GB0723725D0 (en) * 2007-12-05 2008-01-16 Ge Healthcare Uk Ltd Apparatus and method for detecting dna damage
EP2237887A2 (en) 2007-12-26 2010-10-13 Seng Enterprises Ltd. Device for the study of living cells
CA2727818A1 (en) * 2008-06-13 2009-12-13 Scott And White Healthcare Characterization of biological samples
US8221411B2 (en) * 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
EP2278332A1 (en) 2009-07-20 2011-01-26 Fondazione Centro San Raffaele del Monte Tabor Method for optical measuring variations of cell membrane conductance
JP5411096B2 (ja) * 2010-08-31 2014-02-12 株式会社堀場製作所 粒子物性測定セル及び粒子物性測定装置
EP2913391B1 (en) * 2012-10-25 2020-07-01 Hamamatsu Photonics K.K. Cell observation device, and cell observation method
WO2014065330A1 (ja) * 2012-10-25 2014-05-01 浜松ホトニクス株式会社 細胞観察装置、電気刺激装置、及び細胞観察方法
AP2016009023A0 (en) 2013-07-19 2016-02-29 Vertex Pharma Sulfonamides as modulators of sodium channels
SG11201604477SA (en) 2013-12-13 2016-07-28 Vertex Pharma Prodrugs of pyridone amides useful as modulators of sodium channels
WO2016098080A1 (en) * 2014-12-19 2016-06-23 The University Of Ottawa Integrating nanopore sensors within microfluidic channel arrays using controlled breakdown
AU2018271110A1 (en) 2017-05-16 2019-12-05 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
CN116987589A (zh) * 2017-10-19 2023-11-03 苏州壹达生物科技有限公司 一种流式电穿孔装置
CA3091012A1 (en) 2018-02-12 2019-08-15 Vertex Pharmaceuticals Incorporated A method of treating pain
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
UA130303C2 (uk) 2019-12-06 2026-01-14 Вертекс Фармасьютикалз Інкорпорейтед Заміщені тетрагідрофурани як модулятори натрієвих каналів
AU2022286438A1 (en) 2021-06-04 2023-11-30 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels
MX2023014378A (es) 2021-06-04 2023-12-15 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofurano carboxamidas como moduladores de canales de sodio.
AU2022284952A1 (en) 2021-06-04 2023-12-14 Vertex Pharmaceuticals Incorporated Solid dosage forms and dosing regimens comprising (2r,3s,4s,5r)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide
WO2022256842A1 (en) 2021-06-04 2022-12-08 Vertex Pharmaceuticals Incorporated Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channels
DE102021210044A1 (de) 2021-09-10 2023-03-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Messsystem, Probenkörper, Elektrodenvorrichtung und Verfahren zum Messen einer Vielzahl von Analyten
KR20250005373A (ko) 2022-04-22 2025-01-09 버텍스 파마슈티칼스 인코포레이티드 통증 치료를 위한 헤테로아릴 화합물
TW202523313A (zh) 2023-10-23 2025-06-16 美商維泰克斯製藥公司 用於治療疼痛之雜芳基化合物
US20250134571A1 (en) * 2023-10-25 2025-05-01 St. Jude Medical, Cardiology Division, Inc. Systems and methods for reducing microbubbles in electroporation applications
US20260001877A1 (en) 2024-06-28 2026-01-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067951A (en) * 1975-11-19 1978-01-10 Bactomatic Inc. Process for making impedance measuring module
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US5187096A (en) * 1991-08-08 1993-02-16 Rensselaer Polytechnic Institute Cell substrate electrical impedance sensor with multiple electrode array
JP3099049B2 (ja) * 1992-07-29 2000-10-16 農林水産省果樹試験場長 電気的細胞融合及び電気的核酸導入のための大量処理用電極
US5661035A (en) * 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
DE19529371C3 (de) * 1995-08-10 2003-05-28 Nmi Univ Tuebingen Mikroelektroden-Anordnung
IL126977A0 (en) * 1996-05-15 1999-09-22 Hyperion Catalysis Int High surface area nanofibers
US5972694A (en) * 1997-02-11 1999-10-26 Mathus; Gregory Multi-well plate
US5981268A (en) * 1997-05-30 1999-11-09 Board Of Trustees, Leland Stanford, Jr. University Hybrid biosensors
WO2000034434A1 (en) * 1998-12-07 2000-06-15 Acacia Biosciences, Inc. Multi-channel electrode arrays
US7399599B2 (en) * 2000-07-10 2008-07-15 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
DE60143064D1 (de) * 2000-07-10 2010-10-21 Vertex Pharma San Diego Llc Ionenkanal-Assayverfahren

Also Published As

Publication number Publication date
EP1303757A2 (en) 2003-04-23
AU7588101A (en) 2002-02-05
AU2006202851B2 (en) 2009-06-04
ES2273868T3 (es) 2007-05-16
DK1303757T3 (da) 2007-02-05
WO2002008748A3 (en) 2002-05-02
AU2009212941A1 (en) 2009-10-01
ATE480771T1 (de) 2010-09-15
CA2413711A1 (en) 2002-01-31
EP1757932A3 (en) 2007-07-18
JP2004514115A (ja) 2004-05-13
AU2006202851A1 (en) 2006-07-27
DE60123797D1 (de) 2006-11-23
EP1303757B1 (en) 2006-10-11
AU2009212941B2 (en) 2012-06-28
WO2002008748A9 (en) 2003-06-12
WO2002008748A2 (en) 2002-01-31
DE60143064D1 (de) 2010-10-21
DE60123797T2 (de) 2007-10-18
EP1757932A2 (en) 2007-02-28
JP5209835B2 (ja) 2013-06-12
EP1757932B1 (en) 2010-09-08
CA2413711C (en) 2012-03-13
AU2001275881B2 (en) 2006-04-06
ATE342504T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
AU7588101A (en) Ion channel assay methods
WO2005022113A3 (en) Ion channel assay methods
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DE60031997D1 (de) Umkehrtransfektionsverfahren
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE60124301D1 (de) Dünnschichtelektroden zum feststellen von herzdepolarisationsignalen
DE69836490D1 (de) Verbesserte elektrochemische zelle
DE60230672D1 (de) Nukleinsäureanreicherung
ATE320482T1 (de) Makroeingekapselte sekretorische zellen
ATE502116T1 (de) Fluoreszierende proteine aus nicht- biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
AU1943401A (en) An environmental chamber for the analysis of live cells
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE267396T1 (de) Identifizierung von zellen während kinetischer versuchsreihen
WO2002033111A3 (en) Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
DE69613016D1 (de) Elektrochemische Zelle
DE69907182D1 (de) Elektrochemische zelle
IL153660A0 (en) Method for introducing nucleic acid and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
ATE227996T1 (de) Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
AR005342A1 (es) Metodo para la manufactura de felodipina
AU3241700A (en) Method of acid concentration following biological oxidative generation of sulfuric acid from sulfides
DE60024451D1 (de) Bindung mehrerer zinkfinger transkriptionsfaktoren an nukleinsäuren
ID27785A (id) Proses pembuatan asam n-fosfonometil iminodiasetat
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
EE04944B1 (et) Bakteriaalsed plasmiidid kasutamiseks ekspressioonivektoritena v?i mikrobioloogilisel analsil
DE69429428D1 (de) Methode zur analyse des dna-gehalts von tumorzellen mittels tumorzellenanreicherung

Legal Events

Date Code Title Description
FG Grant or registration